Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inari Medical Inc
(NQ:
NARI
)
43.34
-2.04 (-4.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Inari Medical Inc
< Previous
1
2
3
4
5
6
Next >
NARI NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 09, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
NARI NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 09, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 09, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,...
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Bragar Eagel & Squire, P.C. Is Investigating Thoughtworks, Chemours, Methanex, and Inari Medical and Encourages Investors to Contact the Firm
March 08, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
NARI LOSS ALERT: ROSEN, A RESPECTED AND LEADING FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 07, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
NARI LOSS ALERT: ROSEN, A RESPECTED AND LEADING FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 07, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 07, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,...
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
March 06, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
NARI INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 06, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
NARI INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 06, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 06, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,...
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
March 06, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
March 06, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox Encourages Inari Medical, Inc Investors with Significant Losses to Contact the Firm
March 06, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox Encourages Inari Medical, Inc Investors with Significant Losses to Contact the Firm
March 06, 2024
NEW YORK, NY - (NewMediaWire) - March 6, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 05, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Inari Medical, Inc. (NARI)
March 01, 2024
From
Kirby McInerney LLP
Via
Business Wire
INARI MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inari Medical, Inc. on Behalf of Inari Medical Stockholders and Encourages Investors to Contact the Firm
February 29, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI
February 29, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
Inari Medical (NASDAQ: NARI): Kaplan Fox Investigates Potential Securities Fraud at Inari Medical
February 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Exposures
Legal
Inari Medical (NASDAQ: NARI): Kaplan Fox Investigates Potential Securities Fraud at Inari Medical
February 29, 2024
NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the...
Via
TheNewswire.com
Topics
Fraud
Exposures
Legal
Inari Medical Reports Fourth Quarter 2023 Financial Results
February 28, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
February 14, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
5 medical stocks growing earnings by triple digits
February 06, 2024
There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning
Via
MarketBeat
Topics
Economy
Exposures
Economy
Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
January 09, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)
November 27, 2023
Clinical study randomizing up to 1,200 patients designed to help change guidelines in treating intermediate-risk Pulmonary Embolism (PE) patients globally
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Closes Acquisition of LimFlow
November 15, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
After blowout earnings, Integer may be headed to new highs
November 07, 2023
A growth strategy that includes both in-house expansion and acquisition activity could keep Integer Holdings Corporation's run going well into 2024.
Via
MarketBeat
Topics
Economy
Exposures
Supply Chain
Inari Medical to Present at Upcoming Investor Conferences
November 02, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Reports Third Quarter 2023 Financial Results
November 01, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
November 01, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical to Announce Third Quarter 2023 Financial Results
October 11, 2023
From
Inari Medical, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.